Barinthus Biotherapeutics Plc ADR
(BRNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -7,408 | -7,608 | -3,951 | -22,698 |
| Depreciation Amortization | 152 | 97 | 49 | 345 |
| Accounts receivable | 927 | 441 | 524 | N/A |
| Accounts payable and accrued liabilities | -2,017 | -1,472 | -1,154 | N/A |
| Other Working Capital | -315 | 950 | -1,285 | 3,068 |
| Other Operating Activity | 2,529 | 2,321 | 1,496 | 603 |
| Operating Cash Flow | $-6,132 | $-5,271 | $-4,321 | $-18,682 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -98 | -68 | -22 | -124 |
| Investing Cash Flow | $-98 | $-68 | $-22 | $-124 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 24,974 | N/A | N/A | N/A |
| Other Financing Activity | -20 | 0 | 0 | 2,044 |
| Financing Cash Flow | $24,954 | $N/A | $N/A | $2,044 |
| Exchange Rate Effect | -526 | -817 | -655 | -444 |
| Beginning Cash Position | 11,432 | 11,432 | 11,432 | 28,638 |
| End Cash Position | 29,630 | 5,276 | 6,435 | 11,432 |
| Net Cash Flow | $18,198 | $-6,156 | $-4,998 | $-17,206 |
| Free Cash Flow | ||||
| Operating Cash Flow | -6,132 | -5,271 | -4,321 | -18,682 |
| Capital Expenditure | -98 | -68 | -22 | N/A |
| Free Cash Flow | -6,230 | -5,339 | -4,343 | -18,682 |